Open AccessResponse by Zelniker et al to Letter Regarding Article, “Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial”
Author(s) -
Thomas A. Zelniker,
Itamar Raz,
Marc S. Sabatine,
Stephen D. Wiviott
Publication year - 2020
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.120.049841
Subject(s) - medicine , dapagliflozin , timi , atrial fibrillation , myocardial infarction , diabetes mellitus , cardiology , thrombolysis , type 2 diabetes mellitus , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom